The Prevalence and Determinants of Hesitancy for Regular COVID-19 Vaccination among Primary Healthcare Patients with Asthma or COPD in Greece: A Cross-Sectional Study

Vaccines, Journal Year: 2024, Volume and Issue: 12(4), P. 414 - 414

Published: April 14, 2024

The emergence of novel coronavirus mutations and signs the waning immunity provided by COVID-19 vaccines underscore importance regular vaccination. This study aimed to investigate prevalence vaccination hesitancy factors that influence it among patients with asthma or chronic obstructive pulmonary disease (COPD) who visited primary care centers. cross-sectional was conducted in six healthcare centers Crete, Greece (October–December 2023). Participants completed a questionnaire, which included questions about socio-demographic characteristics, health status, previous booster vaccination, attitudes, beliefs Multivariate logistic regression used identify influenced vaccine hesitancy. Of 264 participants, 65% exhibited towards Female gender, middle age, lower educational attainment, depression diagnosis, concerns side effects, lack confidence efficacy, reliance on media information were positively associated Conversely, those having cardiovascular type 2 diabetes, generally adhering recommendations treating physician, previously received flu more than three doses vaccinations. Consequently, our findings could help develop strategies potentially reduce COPD.

Language: Английский

---

Risk and Protective Factors for COVID‐19 Infection among Pregnant Women with Sickle Cell Trait

Advances in Hematology, Journal Year: 2024, Volume and Issue: 2024(1)

Published: Jan. 1, 2024

Pregnant women and individuals with sickle cell trait (SCT) underlying comorbidities are both independently more vulnerable to severe illness from coronavirus disease 2019 (COVID‐19) compared nonpregnant those without SCT. However, our understanding of the specific factors influencing susceptibility COVID‐19 infection among pregnant SCT is currently constrained by limited available data. This study aims determine risk protective that influence likelihood in this population. A retrospective analysis was done 151 reproductive age group. Multivariable performed various affecting The found COVID‐19‐vaccinated had a 90% lower contracting were 9 times likely have if they history pulmonary conditions such as asthma or chronic obstructive disease. present further emphasizes importance vaccine preventing safeguarding health SCT, particularly comorbidities.

Language: Английский

---

Assessing COVID-19 Vaccine Effectiveness and Risk Factors for Severe Outcomes through Machine Learning Techniques: A Real-World Data Study in Andalusia, Spain

Journal of Epidemiology and Global Health, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 11, 2024

Language: Английский

---

Comorbid asthma decreased the risk for COVID-19 mortality in the United Kingdom: Evidence based on a meta-analysis

International Immunopharmacology, Journal Year: 2023, Volume and Issue: 120, P. 110365 - 110365

Published: May 22, 2023

Language: Английский

---

AB2CO risk score for in-hospital mortality of COVID-19 patients admitted to intensive care units

Respiratory Medicine, Journal Year: 2024, Volume and Issue: 227, P. 107635 - 107635

Published: April 17, 2024

Language: Английский

---

Lung function at 1-year follow-up in patients with persistent dyspnea after mild COVID-19 – comparisons with moderate and critical COVID-19

Upsala Journal of Medical Sciences, Journal Year: 2024, Volume and Issue: 129, P. e10740 - e10740

Published: Sept. 3, 2024

Aim: To assess lung function in patients with persistent dyspnea 1 year after mild coronavirus disease 2019 (COVID-19) and compare those hospitalized moderate or critical COVID-19. Methods: Adults confirmed severe acute respiratory syndrome coronavirus-2 infection COVID-19 (n = 18) 34) 19) were followed up 11–13 months initial infection. Inclusion criteria age < 65 years, no smoking history, preexisting diseases. Sociodemographic clinical data collected, underwent spirometry measurement of diffusing capacity for carbon monoxide (DLCO). Results: The non-hospitalized significantly younger more often female compared the groups (P 0.002 P 0.001, respectively). No significant differences comorbidities body mass index (BMI) noted between severity groups. An obstructive pattern (ratio forced expiratory volume during first exhalation second to vital under lower limit normal (LLN)) was found 5.6, 5.9, 5.3% mild, moderate, groups, respectively 0.995). Abnormal DLCO (< LLN) rates seen 16.7, 47.4% 0.018). DLCO, expressed as a z-score, group adjustment age, sex, BMI. Conclusion: Only few subjects had abnormal infection, assessed based on measurements. at 1-year follow-up uncommon even Impaired common

Language: Английский

---

Enoxaparin Posology According to Prothrombotic Status and Bleeding Risk in Hospitalized Patients with SARS-CoV-2 Pneumonia

Journal of Clinical Medicine, Journal Year: 2023, Volume and Issue: 12(3), P. 928 - 928

Published: Jan. 25, 2023

Some patients with COVID-19 have complex hypercoagulable abnormalities that are related to mortality. The optimal dosage of low molecular weight heparin in hospitalized SARS-CoV-2 pneumonia is still not clear. Our objective evaluate the effects adapting thrombotic and bleeding risk scales this setting. We performed a cohort, retrospective, observational, analytical study at Hospital Universitario Jerez de la Frontera, admitted from 1 October 2020 31 January 2021. They were classified according whether they received prophylactic, intermediate, or therapeutic doses enoxaparin. primary endpoint was intrahospital Secondary endpoints need for invasive ventilation, thromboembolic events, bleeding, usefulness scales. After binary logistic regression analysis, considering confounding variables, it found use enoxaparin associated lower mortality during admission compared prophylactic intermediate (RR 0.173; 95% CI, 0.038-0.8; p = 0.025). IMPROVE score correlated higher minor 1.263; 1.105-1.573; 0.037). In adult presenting elevated D-dimer severe proinflammatory state, can be considered, especially if score.

Language: Английский

---

Clinical Outcomes of COVID-19 Infection among Patients with Chronic Obstructive Pulmonary Disease: Findings from the Philippine CORONA Study

Published: Sept. 21, 2023

Background: The global pandemic of coronavirus disease 2019 (COVID-19) resulted to many deaths from fulminant respiratory failure. Chronic obstructive pulmonary (COPD) is the leading cause morbidity and mortality worldwide. There has been great concern regarding impact COPD on COVID-19 illness. Methods: Data Philippine CORONA Study were analyzed determine association in terms mortality, severity, failure, mechanical ventilation, lengths stay intensive care unit (ICU) hospital. influence smoking severity also reviewed. Results: A total 10,881 patients included study 156 (1.4%) had diagnosed with COPD. Majority other existing comorbidities: hypertension, diabetes mellitus, chronic cardiac disease, kidney disease. more commonly present severe or critical COVID-19. at higher risk experience in-hospital be admitted ICU. Smokers likely mortality. Conclusion: Our supports that growing evidence among a for form COVID-19, ICU admission, failure needing ventilatory support. Smoking increases developing

Language: Английский

---

Clinical Outcomes of COVID-19 Infection among Patients with Chronic Obstructive Pulmonary Disease: Findings from the Philippine CORONA Study

Clinics and Practice, Journal Year: 2023, Volume and Issue: 13(6), P. 1383 - 1392

Published: Nov. 10, 2023

The global pandemic caused by the coronavirus disease 2019 (COVID-19) resulted in many deaths from fulminant respiratory failure. Chronic obstructive pulmonary (COPD) is leading cause of morbidity and mortality worldwide. There has been great concern regarding impact COPD on COVID-19 illness.Data Philippine CORONA study were analyzed to determine association terms mortality, severity, failure, mechanical ventilation, lengths stay intensive care unit (ICU) hospital.A total 10,881 patients included this study, 156 (1.4%) had diagnosed with COPD. A majority other existing comorbidities: hypertension, diabetes mellitus, chronic cardiac disease, kidney disease. 2.0× more likely present severe critical our have a 1.7× increased 1.6× risk for ICU admission. Smokers 1.8× 1.9× mortality.Our supports growing evidence that among factor higher form COVID-19, admission, failure needing ventilatory support.

Language: Английский

---

Estudio de sobrevida a largo plazo en pacientes adultos con enfermedades respiratorias crónicas atendidos por infección respiratoria aguda por coronavirus SARS-CoV-2

Revista chilena de enfermedades respiratorias, Journal Year: 2023, Volume and Issue: 39(3), P. 203 - 215

Published: Jan. 1, 2023

La enfermedad respiratoria aguda por coronavirus SARS-CoV-2 (COVID-19) se ha convertido en un grave problema de salud pública a nivel mundial.

---